119 related articles for article (PubMed ID: 11119561)
21. Effects of dynamin inactivation on pathways of anthrax toxin uptake.
Boll W; Ehrlich M; Collier RJ; Kirchhausen T
Eur J Cell Biol; 2004 Jul; 83(6):281-8. PubMed ID: 15511085
[TBL] [Abstract][Full Text] [Related]
22. The ras-related protein Ral is monoglucosylated by Clostridium sordellii lethal toxin.
Hofmann F; Rex G; Aktories K; Just I
Biochem Biophys Res Commun; 1996 Oct; 227(1):77-81. PubMed ID: 8858106
[TBL] [Abstract][Full Text] [Related]
23. A single amino acid substitution in the enzymatic domain of cytotoxic necrotizing factor type 1 of Escherichia coli alters the tissue culture phenotype to that of the dermonecrotic toxin of Bordetella spp.
McNichol BA; Rasmussen SB; Meysick KC; O'Brien AD
Mol Microbiol; 2006 May; 60(4):939-50. PubMed ID: 16677305
[TBL] [Abstract][Full Text] [Related]
24. Binding and entry of Clostridium difficile toxin B is mediated by multiple domains.
Manse JS; Baldwin MR
FEBS Lett; 2015 Dec; 589(24 Pt B):3945-51. PubMed ID: 26602083
[TBL] [Abstract][Full Text] [Related]
25. Clostridium difficile toxins: more than mere inhibitors of Rho proteins.
Genth H; Dreger SC; Huelsenbeck J; Just I
Int J Biochem Cell Biol; 2008; 40(4):592-7. PubMed ID: 18289919
[TBL] [Abstract][Full Text] [Related]
26. Fused polycationic peptide mediates delivery of diphtheria toxin A chain to the cytosol in the presence of anthrax protective antigen.
Blanke SR; Milne JC; Benson EL; Collier RJ
Proc Natl Acad Sci U S A; 1996 Aug; 93(16):8437-42. PubMed ID: 8710889
[TBL] [Abstract][Full Text] [Related]
27. Comparison of wild type with recombinant Clostridium difficile toxin A.
Gerhard R; Burger S; Tatge H; Genth H; Just I; Hofmann F
Microb Pathog; 2005; 38(2-3):77-83. PubMed ID: 15748809
[TBL] [Abstract][Full Text] [Related]
28. A fragment of anthrax lethal factor delivers proteins to the cytosol without requiring protective antigen.
Kushner N; Zhang D; Touzjian N; Essex M; Lieberman J; Lu Y
Proc Natl Acad Sci U S A; 2003 May; 100(11):6652-7. PubMed ID: 12740437
[TBL] [Abstract][Full Text] [Related]
29. Regulation by rho family GTPases of IL-1 receptor induced signaling: C3-like chimeric toxin and Clostridium difficile toxin B inhibit signaling pathways involved in IL-2 gene expression.
Dreikhausen U; Varga G; Hofmann F; Barth H; Aktories K; Resch K; Szamel M
Eur J Immunol; 2001 May; 31(5):1610-9. PubMed ID: 11465119
[TBL] [Abstract][Full Text] [Related]
30. Autocatalytic cleavage of Clostridium difficile toxin B.
Reineke J; Tenzer S; Rupnik M; Koschinski A; Hasselmayer O; Schrattenholz A; Schild H; von Eichel-Streiber C
Nature; 2007 Mar; 446(7134):415-9. PubMed ID: 17334356
[TBL] [Abstract][Full Text] [Related]
31. Protection from Clostridium difficile toxin B-catalysed Rac1/Cdc42 glucosylation by tauroursodeoxycholic acid-induced Rac1/Cdc42 phosphorylation.
Brandes V; Schelle I; Brinkmann S; Schulz F; Schwarz J; Gerhard R; Genth H
Biol Chem; 2012 Jan; 393(1-2):77-84. PubMed ID: 22628301
[TBL] [Abstract][Full Text] [Related]
32. Critical roles of Clostridium difficile toxin B enzymatic activities in pathogenesis.
Li S; Shi L; Yang Z; Zhang Y; Perez-Cordon G; Huang T; Ramsey J; Oezguen N; Savidge TC; Feng H
Infect Immun; 2015 Feb; 83(2):502-13. PubMed ID: 25404023
[TBL] [Abstract][Full Text] [Related]
33. Structure and mode of action of clostridial glucosylating toxins: the ABCD model.
Jank T; Aktories K
Trends Microbiol; 2008 May; 16(5):222-9. PubMed ID: 18394902
[TBL] [Abstract][Full Text] [Related]
34. Cellular uptake of Clostridium difficile toxin B. Translocation of the N-terminal catalytic domain into the cytosol of eukaryotic cells.
Pfeifer G; Schirmer J; Leemhuis J; Busch C; Meyer DK; Aktories K; Barth H
J Biol Chem; 2003 Nov; 278(45):44535-41. PubMed ID: 12941936
[TBL] [Abstract][Full Text] [Related]
35. Listeria monocytogenes induced Rac1-dependent signal transduction in endothelial cells.
Schmeck B; Beermann W; van Laak V; Opitz B; Hocke AC; Meixenberger K; Eitel J; Chakraborty T; Schmidt G; Barth H; Suttorp N; Hippenstiel S
Biochem Pharmacol; 2006 Nov; 72(11):1367-74. PubMed ID: 16884694
[TBL] [Abstract][Full Text] [Related]
36. Chimeric clostridial cytotoxins: identification of the N-terminal region involved in protein substrate recognition.
Hofmann F; Busch C; Aktories K
Infect Immun; 1998 Mar; 66(3):1076-81. PubMed ID: 9488398
[TBL] [Abstract][Full Text] [Related]
37. Dominant-negative mutants of a toxin subunit: an approach to therapy of anthrax.
Sellman BR; Mourez M; Collier RJ
Science; 2001 Apr; 292(5517):695-7. PubMed ID: 11326092
[TBL] [Abstract][Full Text] [Related]
38. Structural characterization of the cell wall binding domains of Clostridium difficile toxins A and B; evidence that Ca2+ plays a role in toxin A cell surface association.
Demarest SJ; Salbato J; Elia M; Zhong J; Morrow T; Holland T; Kline K; Woodnutt G; Kimmel BE; Hansen G
J Mol Biol; 2005 Mar; 346(5):1197-206. PubMed ID: 15713474
[TBL] [Abstract][Full Text] [Related]
39. Localization of the glucosyltransferase activity of Clostridium difficile toxin B to the N-terminal part of the holotoxin.
Hofmann F; Busch C; Prepens U; Just I; Aktories K
J Biol Chem; 1997 Apr; 272(17):11074-8. PubMed ID: 9111001
[TBL] [Abstract][Full Text] [Related]
40. Human neutrophils are activated by a peptide fragment of Clostridium difficile toxin B presumably via formyl peptide receptor.
Goy SD; Olling A; Neumann D; Pich A; Gerhard R
Cell Microbiol; 2015 Jun; 17(6):893-909. PubMed ID: 25529763
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
